STERIS PLC

STENYSE

🏆 #487 by market capEarnings Nov 4US Equity

$234.71▼ $3.47 (−1.48%)

Live

1h▲ 0.3%

24h▼ 1.5%

7d▲ 1.0%

14d▼ 0.1%

30d▲ 8.1%

1y▼ 3.7%

🏦Market Cap

$22.87B

Mid Cap

📈Revenue Growth (YoY)

+8.7%

Slowing

📊Gross Margin

44.4%

Healthy

💵FCF Margin

15.3%

Healthy

⚖️P/S Ratio

3.8x

Fair

Otter Score

Weak

Trading Snapshot

Day Range: $231.82 – $237.91
52-Week Range: $195.14 – $269.44
Volume: $3.05B
Avg Volume: $2.15B
Shares Outstanding: 97.5M
Next Earnings: Sep 25, 2026

Fundamentals Snapshot

Annual Revenue: $5.94B
Last Q Revenue: $1.49B
P/E Ratio: 28.6
P/S Ratio: 3.8x
EPS (TTM): $8.25
Dividend Yield: 1.07%

Why Investors Own STE

✓High-growth profile — revenue up +58.1% YoY with expanding US Equity exposure.
✓Healthy economics — 63% gross margin and 16% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$5.94B▲ +60.4% YoY

Gross Margin (TTM)

63.2%▲ +0.4% YoY

Operating Income (TTM)

$635M▲ +60.4% YoY

Free Cash Flow (TTM)

$950M▲ +60.4% YoY

About STERIS PLC

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It also provides services such as equipment maintenance, instrument repair, and contract sterilization for medical device and pharmaceutical manufacturers.

🦦